Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
+972K
-
Total reported value, excl. options
-
$252M
-
Value change
-
+$10.1M
-
Number of buys
-
44
-
Number of sells
-
-31
-
Price
-
$15.96
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2015
85 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q3 2015.
Evolent Health, Inc. - Class A Common Stock (EVH) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 112M outstanding shares and own 14.14% of the company stock.
Largest 10 shareholders include TPG Group Holdings (SBS) Advisors, Inc. (2.38M shares), LORD, ABBETT & CO. LLC (1.93M shares), FMR LLC (1.61M shares), JPMORGAN CHASE & CO (916K shares), GOLDMAN SACHS GROUP INC (913K shares), TimesSquare Capital Management, LLC (823K shares), Pennant Capital Management, LLC (759K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (754K shares), VANGUARD GROUP INC (701K shares), and WELLS FARGO & COMPANY/MN (663K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.